tiprankstipranks
COSCIENS Biopharma (DE:ET80)
FRANKFURT:ET80
Germany Market
ET80
COSCIENS Biopharma
RESEARCH TOOLSreports

COSCIENS Biopharma (ET80) Ratios

0 Followers

COSCIENS Biopharma Ratios

DE:ET80's free cash flow for Q1 2026 was $0.42. For the 2026 fiscal year, DE:ET80's free cash flow was decreased by $ and operating cash flow was $-0.39. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Mar 25Dec 23Dec 22
Liquidity Ratios
Current Ratio
 5.57 3.18 3.32 8.01 7.88
Quick Ratio
 4.92 2.82 2.95 7.13 7.84
Cash Ratio
 2.97 2.02 2.27 7.49 7.18
Solvency Ratio
 -1.72 -0.53 -0.63 -0.19 0.16
Operating Cash Flow Ratio
 -5.16 -2.39 -2.02 -3.77 -1.94
Short-Term Operating Cash Flow Coverage
 -46.78 -40.17 0.00 -57.31 -50.12
Net Current Asset Value
$ 5.88M$ -6.08M$ 2.07M$ 17.55M$ 35.24M
Leverage Ratios
Debt-to-Assets Ratio
 0.11 0.10 0.07 0.09 0.07
Debt-to-Equity Ratio
 0.13 0.56 0.18 0.19 0.11
Debt-to-Capital Ratio
 0.12 0.36 0.15 0.16 0.10
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.07 0.04
Financial Leverage Ratio
 1.23 5.58 2.66 2.03 1.57
Debt Service Coverage Ratio
 -19.39 -24.45 -105.22 -38.71 -44.42
Interest Coverage Ratio
 -52.84 -62.15 -108.71 -140.54 -160.58
Debt to Market Cap
 0.10 0.10 0.00 0.05 0.03
Interest Debt Per Share
 6.21 6.59 0.94 0.72 0.81
Net Debt to EBITDA
 0.47 0.55 1.04 1.70 3.04
Profitability Margins
Gross Profit Margin
37.96%35.30%49.33%95.06%97.22%
EBIT Margin
-96.00%-139.25%-157.46%-400.36%77.17%
EBITDA Margin
-80.77%-123.41%-140.70%-400.00%-272.36%
Operating Profit Margin
-96.00%-139.25%-146.27%-400.36%-272.64%
Pretax Profit Margin
-87.57%-138.01%-158.81%-367.99%-402.96%
Net Profit Margin
-92.11%-138.14%-159.68%-78.93%57.46%
Continuous Operations Profit Margin
-87.71%-138.14%-159.68%-78.93%57.46%
Net Income Per EBT
105.18%100.10%100.55%21.45%-14.26%
EBT Per EBIT
91.22%99.11%108.57%91.91%147.80%
Return on Assets (ROA)
-38.59%-49.27%-43.65%-9.59%5.78%
Return on Equity (ROE)
-92.88%-274.82%-116.32%-19.51%9.06%
Return on Capital Employed (ROCE)
-44.16%-59.73%-50.36%-55.45%-31.39%
Return on Invested Capital (ROIC)
-43.69%-59.02%-49.87%-49.62%-31.05%
Return on Tangible Assets
-38.59%-49.27%-43.65%-9.59%5.79%
Earnings Yield
-412.48%-483.00%-73.70%-9.43%5.26%
Efficiency Ratios
Receivables Turnover
 3.96 6.06 3.88 15.54 2.65
Payables Turnover
 8.24 6.64 2.02 0.12 0.08
Inventory Turnover
 4.46 3.78 1.81 0.06 0.69
Fixed Asset Turnover
 0.85 0.78 0.87 14.19 26.11
Asset Turnover
 0.42 0.36 0.27 0.12 0.10
Working Capital Turnover Ratio
 1.01 0.62 0.39 0.11 0.10
Cash Conversion Cycle
 129.85 101.70 115.41 3.54K -4.07K
Days of Sales Outstanding
 92.21 60.22 94.08 23.49 137.57
Days of Inventory Outstanding
 81.91 96.47 202.19 6.58K 532.39
Days of Payables Outstanding
 44.27 54.99 180.85 3.07K 4.74K
Operating Cycle
 174.13 156.69 296.26 6.60K 669.96
Cash Flow Ratios
Operating Cash Flow Per Share
 -24.95 -24.51 -5.64 -3.53 -2.82
Free Cash Flow Per Share
 -25.20 -26.56 -6.09 -3.53 -2.82
CapEx Per Share
 0.25 2.04 0.45 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.01 1.08 1.08 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -98.83 -12.00 -12.55 -900.95 -1.24K
Capital Expenditure Coverage Ratio
 -98.83 -12.00 -12.55 -900.95 -1.24K
Operating Cash Flow Coverage Ratio
 -4.30 -4.02 -6.31 -5.05 -3.54
Operating Cash Flow to Sales Ratio
 -1.10 -1.13 -1.52 -3.81 -2.43
Free Cash Flow Yield
-491.91%-428.03%-75.72%-45.54%-22.22%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.33 -0.21 -1.36 -4.04 6.79
Price-to-Sales (P/S) Ratio
 0.23 0.29 2.17 8.37 10.92
Price-to-Book (P/B) Ratio
 0.12 0.57 1.58 2.07 1.72
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.20 -0.23 -1.32 -2.20 -4.50
Price-to-Operating Cash Flow Ratio
 -0.20 -0.25 -1.43 -2.20 -4.50
Price-to-Earnings Growth (PEG) Ratio
 -0.01 >-0.01 >-0.01 0.02 0.17
Price-to-Fair Value
 0.12 0.57 1.58 2.07 1.72
Enterprise Value Multiple
 0.19 0.32 -0.50 -0.39 -0.97
Enterprise Value
 -1.20M -2.97M 6.69M 7.01M 14.86M
EV to EBITDA
 0.19 0.32 -0.50 -0.39 -0.97
EV to Sales
 -0.15 -0.39 0.70 1.56 2.64
EV to Free Cash Flow
 0.14 0.32 -0.43 -0.41 -1.09
EV to Operating Cash Flow
 0.14 0.34 -0.46 -0.41 -1.09
Tangible Book Value Per Share
 43.92 10.90 5.10 3.75 7.36
Shareholders’ Equity Per Share
 43.93 10.90 5.10 3.75 7.37
Tax and Other Ratios
Effective Tax Rate
 >-0.01 >-0.01 >-0.01 0.09 -0.04
Revenue Per Share
 22.63 21.69 3.71 0.93 1.16
Net Income Per Share
 -20.85 -29.97 -5.93 -0.73 0.67
Tax Burden
 1.05 1.00 1.01 0.21 -0.14
Interest Burden
 0.91 0.99 1.01 0.92 -5.22
Research & Development to Revenue
 0.25 0.39 0.87 3.01 2.22
SG&A to Revenue
 1.08 1.34 1.09 1.94 1.46
Stock-Based Compensation to Revenue
 -0.01 0.00 0.05 0.04 0.01
Income Quality
 1.26 0.82 0.95 4.82 -4.22
Currency in USD